Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss. Carlo-Stella C. Br J Haematol 2024;205:17-19.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carlo-Stella C. Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss. Br J Haematol 2024;205:17-19.
PMID: 38813657